SpotSee Maps Four Cold-Chain Monitoring Tiers for Cell, Gene Therapy
Image
Global – October 20, 2026 -- The International Society for Cell & Gene Therapy (ISCT) has made cold-chain readiness a specific focus for 2026, and SpotSee is outlining how shippers can match temperature-monitoring technology to the evidence their quality teams need.
ISCT's Cold Chain Management and Logistics Working Group is addressing cryopreservation, storage, shipping, handling and thawing. Therapies can pass through manufacturing sites, storage locations, specialized logistics providers and clinical sites. For autologous therapies, patient-derived material is collected, shipped for manufacturing and returned to the same patient, so each hand-off may require proof that temperature requirements held.